Klaciped

Klaciped is a medicine authorised by Swissmedic under authorisation number 51608. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 27 May 1993 and the authorisation is valid without a time limit. ATC code J01FA09 places the medicine in the group Antibacterials for systemic use.

Dispensing category A
Authorisation number 51608
ATC J01FA09
Synthetic medicines

Authorisation data
Authorisation number	51608
Name	Klaciped
Full name	Klaciped, Granulat zur Herstellung einer Kindersuspension zum Einnehmen
Authorisation holder	Viatris Pharma GmbH
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	J01FA09
First authorisation	27 May 1993
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Klaciped, Granulat zur Herstellung einer Kindersuspension zum Einnehmen	A	27 May 1993
2	Klaciped Forte, Granulat zur Herstellung einer Kindersuspension zum Einnehmen	A	02 June 1999

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	100	ml	J01FA09	08.01.6.	A
2	100	ml	J01FA09	08.01.6.	A

Scroll the table sideways

Medicines in the same ATC group

Clarithro Labatec i.v. 500 mgAuthorisation number 70262 · Labatec Pharma SA · ATC J01FA09A Clarithromycin Sandoz 250Authorisation number 57129 · Sandoz Pharmaceuticals AG · ATC J01FA09A Clarithromycin Spirig HC 125Authorisation number 57770 · Spirig HealthCare AG · ATC J01FA09A Clarithromycin Spirig HC 250 mgAuthorisation number 67169 · Spirig HealthCare AG · ATC J01FA09A Clarithromycin-Mepha 125Authorisation number 57192 · Mepha Pharma AG · ATC J01FA09A Clarithromycin-Mepha 250Authorisation number 57130 · Mepha Pharma AG · ATC J01FA09A Clarithromycine Labatec 500 mg i.v.Authorisation number 59480 · Labatec Pharma SA · ATC J01FA09A Klacid 250 mgAuthorisation number 50469 · Viatris Pharma GmbH · ATC J01FA09A Klacid i.v.Authorisation number 51759 · Viatris Pharma GmbH · ATC J01FA09A

Other medicines from this authorisation holder

Abirateron Viatris 500 mgAuthorisation number 68890 · ATC L02BX03B AcetocaustinAuthorisation number 45209 · ATC D11AFB AcnatacAuthorisation number 62513 · ATC D10AF51A Aldara 5 %Authorisation number 55070 · ATC D06BB10A Amlodipin Viatris 5 mgAuthorisation number 59261 · ATC C08CA01B Amlodipin/Valsartan Viatris 5 mg/80 mgAuthorisation number 68131 · ATC C09DB01B Apixaban Viatris 2.5 mgAuthorisation number 70071 · ATC B01AF02B Arixtra 2.5 mg/0.5 mlAuthorisation number 55937 · ATC B01AX05B

Frequently asked questions

Is Klaciped authorised in Switzerland?

Yes. Klaciped is authorised by Swissmedic under authorisation number 51608, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Klaciped have?

Klaciped is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Klaciped?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.